Skip to main content

Parkwalk Advisors — Portfolio, Page 3

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

173
Companies
$2.3B
Total invested
$13.4M
Avg. check
44
Industries
Health Care 10Biotechnology 9Software 7Information Technology 5Life Science 4Medical 4+38 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 49–72 of 173
Echion Technologies
November 2024

Echion Technologies develops XNO anode materials designed for Li-ion batteries used in heavy-duty electric vehicles.

Battery · Cambridge$12.6M Venture - Series Unknown
Ikarovec
October 2024

Ikarovek is working on early stage assets intended for the treatment of diabetic macular edama.

Biotechnology · Cambridge$10.3M Seed
Cheesecake Energy
September 2024

Cheesecake Energy is developing advanced thermal and compressed air energy systems to store energy.

Energy · NottinghamGrant
Evoralis
September 2024

Evoralis is an enzyme development company that specializes in the discovery and development of plastic-depolymerizing enzymes.

Biotechnology · Cambridge$3.3M Seed
PhoreMost
September 2024

PhoreMost is a new-model drug discovery company based in Cambridge, UK.

Biopharma · Cambridge$12.0M Series B
OW Smell Made Digital
August 2024

OW Smell Made Digital offers software and hardware solutions for controlling smell.

Hardware · London$1.9M Seed
Riverlane
August 2024

Riverlane develops software solutions to harness the power of quantum computers for practical applications.

Computer · Cambridge$75.0M Series C
Sano Genetics
July 2024

Sano Genetics is a molecular diagnostics company that specializes in developing and commercializing genetic tests for inherited diseases.

Biopharma · CambridgeNon-equity Assistance
Oxford Endovascular
May 2024

Oxford Endovascular are developing a novel treatment for treating brain aneurysms.

Biotechnology · Oxford$10.2M Series A
GaitQ
April 2024

gaitQ® develops innovative wearable technology that improves people’s mobility and quality of life.

Health Care · OxfordGrant
MeVitae
February 2024

Deep tech company helping companies find talent smarter, faster and fairer without unconscious or algorithmic bias.

Artificial Intelligence (AI) · Oxford$1.8M Seed
Koalaa
February 2024

Koalaa offers comfy, soft prosthetic arms and personalized support, for babies, kids, and adults.

Health Care · London$1.2M Seed
Concr
February 2024

Astrophysics technology for precision therapy through accurate modelling of biology

Biopharma · LondonGrant
Wayland Additive
January 2024

Wayland Additive Limited is a West-Yorkshire based company pushing the boundaries of electron beam 3D printing.

3D Printing · Huddersfield$5.3M Series A
Albus Health
December 2023

A med-tech startup that has developed a passive and contactless device for monitoring nocturnal symptoms and environmental metrics at home.

Biotechnology · OxfordVenture - Series Unknown
Proxisense
November 2023

Proxisense has developed extreme environment proximity sensors and fluid contamination systems.

Hardware · Oxford$1.3M Series A
Mogrify
October 2023

MogrifyAE will transform the lives of patients with degenerative diseases through a novel class of in vivo reprogramming therapies.

Big Data · Cambridge$10.0M Series A
Fresh Check
September 2023

Visible warning of bacterial infection in packaging.

Fitness · London$620K Seed
Crypto Quantique
September 2023

Crypto Quantique offers hardware based cyber-security solution for authentication and encryption in a wired local network.

Cyber Security · City Of LondonNon-equity Assistance
Phasecraft
August 2023

Phasecraft is a quantum computing software developer.

Computer · London$16.5M Series A
Entia
July 2023

Entia is a medical technology company that specializes in improving access to blood test.

Health Care · London$20.7M Series A
NK:IO
July 2023

NK:IO is a biotech company that develops novel approaches to natural killer cell-mediated immunotherapy.

Biotechnology · London$1.5M Seed
Cambridge Touch Technologies Ltd.
May 2023

Pressure Sensitive Multi-Touch for Next-Generation Smart Devices including Smartphones, Tablets, Automotive and Industrial

Automotive · Cambridge$5.1M Series B
Signaloid
May 2023

Signaloid is a cloud-based computing platform.

Artificial Intelligence (AI) · Cambridge$3.7M Seed

Where Parkwalk Advisors invests

Health Care10
Biotechnology9
Software7
Information Technology5
Life Science4
Medical4

About Parkwalk Advisors's portfolio

How many companies has Parkwalk Advisors invested in?▸

Parkwalk Advisors has invested in 173 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Parkwalk Advisors invest in?▸

Parkwalk Advisors's top investment sectors include Health Care, Biotechnology, Software, Information Technology, Life Science. The firm invests across 44 different industry categories.

What is Parkwalk Advisors's largest investment?▸

Among tracked funding rounds, Riverlane received $75.0M in a Series C round. Parkwalk Advisors's total known invested capital is $2.3B.

What is the average investment size for Parkwalk Advisors?▸

Parkwalk Advisors's average investment size is $13.4M across its portfolio of 173 companies.

What are Parkwalk Advisors's most recent investments?▸

Recent Parkwalk Advisors portfolio additions include Echion Technologies, Ikarovec, Cheesecake Energy, Evoralis, PhoreMost. These companies were founded in 2020 or later.

Reach the founders behind these 173 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →